234 related articles for article (PubMed ID: 27759076)
1. Identification of reference genes for circulating microRNA analysis in colorectal cancer.
Niu Y; Wu Y; Huang J; Li Q; Kang K; Qu J; Li F; Gou D
Sci Rep; 2016 Oct; 6():35611. PubMed ID: 27759076
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
4. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
5. Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder.
Liu X; Zhang L; Cheng K; Wang X; Ren G; Xie P
J Affect Disord; 2014 Jul; 163():133-9. PubMed ID: 24479999
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients.
Zheng G; Wang H; Zhang X; Yang Y; Wang L; Du L; Li W; Li J; Qu A; Liu Y; Wang C
PLoS One; 2013; 8(12):e83025. PubMed ID: 24349425
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
9. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
10. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
[TBL] [Abstract][Full Text] [Related]
11. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
12. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
Wang YN; Chen ZH; Chen WC
Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
[TBL] [Abstract][Full Text] [Related]
13. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.
Zalewski K; Misiek M; Kowalik A; Bakuła-Zalewska E; Kopczyński J; Zielińska A; Bidziński M; Radziszewski J; Góźdź S; Kowalewska M
Tumour Biol; 2017 Nov; 39(11):1010428317717140. PubMed ID: 29299981
[TBL] [Abstract][Full Text] [Related]
14. Reference miRNAs for miRNAome analysis of urothelial carcinomas.
Ratert N; Meyer HA; Jung M; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
PLoS One; 2012; 7(6):e39309. PubMed ID: 22745731
[TBL] [Abstract][Full Text] [Related]
15. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
16. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
17. A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types.
Pastor-Navarro B; García-Flores M; Fernández-Serra A; Blanch-Tormo S; Martínez de Juan F; Martínez-Lapiedra C; Maia de Alcantara F; Peñalver JC; Cervera-Deval J; Rubio-Briones J; García-Rupérez J; López-Guerrero JA
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316350
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab.
Halvorsen AR; Sandhu V; Sprauten M; Flote VG; Kure EH; Brustugun OT; Helland Å
Acta Oncol; 2018 Sep; 57(9):1225-1231. PubMed ID: 29683761
[TBL] [Abstract][Full Text] [Related]
19. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
20. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity.
Belmonte T; Perez-Pons M; Benítez ID; Molinero M; García-Hidalgo MC; Rodríguez-Muñoz C; Gort-Paniello C; Moncusí-Moix A; Madè A; Devaux Y; Martelli F; Ortega A; González J; Torres G; Barbé F; de Gonzalo-Calvo D
Int J Biol Macromol; 2024 Jun; 269(Pt 2):131926. PubMed ID: 38688344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
